- User Profile
- Watchlists
- Gesundheitswesen & Finanzdienstleistungen
Gesundheitswesen & Finanzdienstleistungen
Watching
50
| Company | Price & Valuation | My FV & Narrative | Valuation | Growth | Analyst Target | |
|---|---|---|---|---|---|---|
HOOD Robinhood Markets US$94.306.8% undervalued intrinsic discount 28.1%7D 24.0%3M | ||||||
CRSP CRISPR Therapeutics US$56.1831.7% undervalued intrinsic discount 11.6%7D -3.2%3M | ||||||
HIMS Hims & Hers Health US$26.1584.9% undervalued intrinsic discount 10.1%7D 65.3%3M | ||||||
TMO Thermo Fisher Scientific US$492.5119.5% undervalued intrinsic discount 9.9%7D -3.1%3M | ||||||
IBKR Interactive Brokers Group US$86.971.1% overvalued intrinsic discount 6.9%7D 25.3%3M | ||||||
DHR Danaher US$182.6726.3% undervalued intrinsic discount 6.2%7D -10.5%3M | ||||||
CRMD CorMedix US$8.4429.7% undervalued intrinsic discount 5.8%7D 22.1%3M | ||||||
BNTX BioNTech US$95.9539.7% undervalued intrinsic discount 4.1%7D -4.8%3M | ||||||
LLY Eli Lilly US$1,105.008.8% undervalued intrinsic discount 3.8%7D 9.7%3M | ||||||
MS Morgan Stanley US$208.009.3% overvalued intrinsic discount 3.5%7D 25.3%3M | ||||||
GS Goldman Sachs Group US$1,025.569.8% overvalued intrinsic discount 2.9%7D 18.9%3M | ||||||
ETOR eToro Group US$41.9871.8% undervalued intrinsic discount 2.8%7D 33.3%3M | ||||||
XRAY DENTSPLY SIRONA US$10.474.7% overvalued intrinsic discount 2.5%7D -21.3%3M | ||||||
COIN Coinbase Global US$189.0350.7% undervalued intrinsic discount 2.2%7D 3.7%3M | ||||||
KKR KKR US$95.9413.6% overvalued intrinsic discount 2.0%7D 6.0%3M | ||||||
HSBC HSBC Holdings US$93.741.7% undervalued intrinsic discount 1.9%7D 9.7%3M | ||||||
SPGI S&P Global US$424.0020.6% undervalued intrinsic discount 1.5%7D -4.5%3M | ||||||
AXP American Express US$316.4716.5% undervalued intrinsic discount 1.5%7D 2.8%3M | ||||||
WFC Wells Fargo US$77.5419.8% undervalued intrinsic discount 1.5%7D -6.0%3M | ||||||
NVO Novo Nordisk US$45.5855.7% undervalued intrinsic discount 1.4%7D 24.3%3M | ||||||
MTB M&T Bank US$216.112.9% overvalued intrinsic discount 1.4%7D -1.3%3M | ||||||
PYPL PayPal Holdings US$44.7525.4% undervalued intrinsic discount 1.2%7D -3.5%3M | ||||||
PFE Pfizer US$26.1810.3% undervalued intrinsic discount 1.1%7D -1.5%3M | ||||||
ABBV AbbVie US$217.7212.7% undervalued intrinsic discount 0.9%7D -6.9%3M | ||||||
EW Edwards Lifesciences US$86.4711.0% undervalued intrinsic discount 0.8%7D 1.4%3M | ||||||
C Citigroup US$125.9014.3% undervalued intrinsic discount 0.6%7D 13.7%3M | ||||||
GILD Gilead Sciences US$134.4314.8% undervalued intrinsic discount 0.05%7D -9.1%3M | ||||||
USB U.S. Bancorp US$54.8513.7% undervalued intrinsic discount 0.04%7D 1.6%3M | ||||||
CRCL Circle Internet Group US$113.0021.9% undervalued intrinsic discount -0.1%7D 13.4%3M | ||||||
BAC Bank of America US$51.6018.3% undervalued intrinsic discount -0.4%7D 3.3%3M | ||||||
MSTR Strategy US$159.0977.4% undervalued intrinsic discount -0.5%7D 19.9%3M | ||||||
AMGN Amgen US$336.794.4% undervalued intrinsic discount -0.7%7D -10.7%3M | ||||||
V Visa US$326.3618.2% undervalued intrinsic discount -0.8%7D 1.7%3M | ||||||
MA Mastercard US$493.9824.4% undervalued intrinsic discount -0.9%7D -5.8%3M | ||||||
FISV Fiserv US$56.5613.1% overvalued intrinsic discount -1.0%7D -10.1%3M | ||||||
NVS Novartis US$150.172.7% undervalued intrinsic discount -1.2%7D -8.5%3M | ||||||
BX Blackstone US$116.9727.9% undervalued intrinsic discount -1.3%7D 5.5%3M | ||||||
ABT Abbott Laboratories US$85.6027.8% undervalued intrinsic discount -2.1%7D -24.7%3M | ||||||
UNH UnitedHealth Group US$380.311.5% undervalued intrinsic discount -2.1%7D 31.5%3M | ||||||
JPM JPMorgan Chase US$299.3111.4% undervalued intrinsic discount -2.3%7D -0.3%3M | ||||||
BLK BlackRock US$1,046.8816.6% undervalued intrinsic discount -2.4%7D -0.5%3M | ||||||
BRK.B Berkshire Hathaway US$474.4899.9% undervalued intrinsic discount -2.4%7D -1.4%3M | ||||||
MRK Merck US$118.728.5% undervalued intrinsic discount -3.0%7D -0.9%3M | ||||||
ISRG Intuitive Surgical US$424.641.3% undervalued intrinsic discount -3.1%7D -14.6%3M | ||||||
SYK Stryker US$305.0921.6% undervalued intrinsic discount -3.6%7D -20.7%3M | ||||||
BMY Bristol-Myers Squibb US$57.189.2% undervalued intrinsic discount -3.8%7D -6.6%3M | ||||||
JNJ Johnson & Johnson US$225.3310.9% undervalued intrinsic discount -3.8%7D -8.7%3M | ||||||
ZTS Zoetis US$77.6937.6% undervalued intrinsic discount -4.5%7D -38.3%3M | ||||||
MDT Medtronic US$73.8131.7% undervalued intrinsic discount -6.1%7D -23.7%3M | ||||||
RMD ResMed US$190.5733.9% undervalued intrinsic discount -8.4%7D -26.2%3M |
Watching
50
| Company | Price & Valuation | My FV & Narrative | Valuation | Growth | Analyst Target | |
|---|---|---|---|---|---|---|
HOOD Robinhood Markets 28.1%7D 24.0%3M | US$94.30 6.8% undervalued intrinsic discount | PE 44.8x | E 12.9% | US$98.77 | ||
CRSP CRISPR Therapeutics 11.6%7D -3.2%3M | US$56.18 31.7% undervalued intrinsic discount | PB 3x | E 64.7% | US$82.24 | ||
HIMS Hims & Hers Health 10.1%7D 65.3%3M | US$26.15 84.9% undervalued intrinsic discount | PS 2.6x | E 50.7% | US$26.61 | ||
TMO Thermo Fisher Scientific 9.9%7D -3.1%3M | US$492.51 19.5% undervalued intrinsic discount | PE 26.7x | E 10.7% | US$611.56 | ||
IBKR Interactive Brokers Group 6.9%7D 25.3%3M | US$86.97 1.1% overvalued intrinsic discount | PE 37.3x | E 13.6% | US$86.30 | ||
DHR Danaher 6.2%7D -10.5%3M | US$182.67 26.3% undervalued intrinsic discount | PE 35.2x | E 19.9% | US$245.39 | ||
CRMD CorMedix 5.8%7D 22.1%3M | US$8.44 29.7% undervalued intrinsic discount | PE 3.7x | E -6.5% | US$15.33 | ||
BNTX BioNTech 4.1%7D -4.8%3M | US$95.95 39.7% undervalued intrinsic discount | PS 7.4x | E 2.3% | US$124.06 | ||
LLY Eli Lilly 3.8%7D 9.7%3M | US$1,105.00 8.8% undervalued intrinsic discount | PE 39x | E 16.4% | US$1,215.10 | ||
MS Morgan Stanley 3.5%7D 25.3%3M | US$208.00 9.3% overvalued intrinsic discount | PE 18.7x | E 3.9% | US$203.29 | ||
GS Goldman Sachs Group 2.9%7D 18.9%3M | US$1,025.56 9.8% overvalued intrinsic discount | PE 18.4x | E 5.5% | US$947.60 | ||
ETOR eToro Group 2.8%7D 33.3%3M | US$41.98 71.8% undervalued intrinsic discount | PE 14x | E 11.3% | US$55.93 | ||
XRAY DENTSPLY SIRONA 2.5%7D -21.3%3M | US$10.47 4.7% overvalued intrinsic discount | PS 0.6x | E 76.9% | US$13.60 | ||
COIN Coinbase Global 2.2%7D 3.7%3M | US$189.03 50.7% undervalued intrinsic discount | PE 62.2x | E 31.9% | US$231.55 | ||
KKR KKR 2.0%7D 6.0%3M | US$95.94 13.6% overvalued intrinsic discount | PE 30.7x | E 26.2% | US$125.64 | ||
HSBC HSBC Holdings 1.9%7D 9.7%3M | US$93.74 1.7% undervalued intrinsic discount | PE 15.2x | E 11.3% | US$95.36 | ||
SPGI S&P Global 1.5%7D -4.5%3M | US$424.00 20.6% undervalued intrinsic discount | PE 26.3x | E 9.0% | US$533.76 | ||
AXP American Express 1.5%7D 2.8%3M | US$316.47 16.5% undervalued intrinsic discount | PE 19.5x | E 8.7% | US$361.57 | ||
WFC Wells Fargo 1.5%7D -6.0%3M | US$77.54 19.8% undervalued intrinsic discount | PE 11.5x | E 4.5% | US$96.11 | ||
NVO Novo Nordisk 1.4%7D 24.3%3M | US$45.58 55.7% undervalued intrinsic discount | PE 10.6x | E 0.5% | US$48.22 | ||
MTB M&T Bank 1.4%7D -1.3%3M | US$216.11 2.9% overvalued intrinsic discount | PE 11.4x | E 2.3% | US$233.17 | ||
PYPL PayPal Holdings 1.2%7D -3.5%3M | US$44.75 25.4% undervalued intrinsic discount | PE 7.8x | E -1.4% | US$52.53 | ||
PFE Pfizer 1.1%7D -1.5%3M | US$26.18 10.3% undervalued intrinsic discount | PE 20x | E -1.0% | US$29.19 | ||
ABBV AbbVie 0.9%7D -6.9%3M | US$217.72 12.7% undervalued intrinsic discount | PE 107x | E 25.2% | US$252.90 | ||
EW Edwards Lifesciences 0.8%7D 1.4%3M | US$86.47 11.0% undervalued intrinsic discount | PE 46.3x | E 16.9% | US$96.65 | ||
C Citigroup 0.6%7D 13.7%3M | US$125.90 14.3% undervalued intrinsic discount | PE 14.6x | E 9.7% | US$146.93 | ||
GILD Gilead Sciences 0.05%7D -9.1%3M | US$134.43 14.8% undervalued intrinsic discount | PE 18.1x | E 21.1% | US$157.83 | ||
USB U.S. Bancorp 0.04%7D 1.6%3M | US$54.85 13.7% undervalued intrinsic discount | PE 11.5x | E 5.3% | US$63.55 | ||
CRCL Circle Internet Group -0.1%7D 13.4%3M | US$113.00 21.9% undervalued intrinsic discount | PS 9.8x | E 49.4% | US$145.80 | ||
BAC Bank of America -0.4%7D 3.3%3M | US$51.60 18.3% undervalued intrinsic discount | PE 12.1x | E 6.1% | US$63.16 | ||
MSTR Strategy -0.5%7D 19.9%3M | US$159.09 77.4% undervalued intrinsic discount | PB 1.5x | E 83.9% | US$376.86 | ||
AMGN Amgen -0.7%7D -10.7%3M | US$336.79 4.4% undervalued intrinsic discount | PE 23.3x | E 8.6% | US$352.23 | ||
V Visa -0.8%7D 1.7%3M | US$326.36 18.2% undervalued intrinsic discount | PE 27.9x | E 10.8% | US$398.74 | ||
MA Mastercard -0.9%7D -5.8%3M | US$493.98 24.4% undervalued intrinsic discount | PE 28x | E 10.9% | US$646.97 | ||
FISV Fiserv -1.0%7D -10.1%3M | US$56.56 13.1% overvalued intrinsic discount | PE 9.4x | E 6.0% | US$69.96 | ||
NVS Novartis -1.2%7D -8.5%3M | US$150.17 2.7% undervalued intrinsic discount | PE 20.4x | E 9.6% | US$154.39 | ||
BX Blackstone -1.3%7D 5.5%3M | US$116.97 27.9% undervalued intrinsic discount | PE 30.1x | E 25.7% | US$143.65 | ||
ABT Abbott Laboratories -2.1%7D -24.7%3M | US$85.60 27.8% undervalued intrinsic discount | PE 23.8x | E 12.6% | US$117.29 | ||
UNH UnitedHealth Group -2.1%7D 31.5%3M | US$380.31 1.5% undervalued intrinsic discount | PE 28.7x | E 15.7% | US$399.73 | ||
JPM JPMorgan Chase -2.3%7D -0.3%3M | US$299.31 11.4% undervalued intrinsic discount | PE 13.9x | E 3.9% | US$342.19 | ||
BLK BlackRock -2.4%7D -0.5%3M | US$1,046.88 16.6% undervalued intrinsic discount | PE 26x | E 8.8% | US$1,251.25 | ||
BRK.B Berkshire Hathaway -2.4%7D -1.4%3M | US$474.48 99.9% undervalued intrinsic discount | PE 14.1x | E -2.4% | US$506.52 | ||
MRK Merck -3.0%7D -0.9%3M | US$118.72 8.5% undervalued intrinsic discount | PE 32.8x | E 21.2% | US$129.74 | ||
ISRG Intuitive Surgical -3.1%7D -14.6%3M | US$424.64 1.3% undervalued intrinsic discount | PE 50.5x | E 12.6% | US$567.80 | ||
SYK Stryker -3.6%7D -20.7%3M | US$305.09 21.6% undervalued intrinsic discount | PE 35x | E 16.5% | US$389.24 | ||
BMY Bristol-Myers Squibb -3.8%7D -6.6%3M | US$57.18 9.2% undervalued intrinsic discount | PE 16.1x | E -1.8% | US$63.08 | ||
JNJ Johnson & Johnson -3.8%7D -8.7%3M | US$225.33 10.9% undervalued intrinsic discount | PE 25.8x | E 8.3% | US$252.87 | ||
ZTS Zoetis -4.5%7D -38.3%3M | US$77.69 37.6% undervalued intrinsic discount | PE 12.2x | E 5.2% | US$124.59 | ||
MDT Medtronic -6.1%7D -23.7%3M | US$73.81 31.7% undervalued intrinsic discount | PE 20.5x | E 11.1% | US$106.56 | ||
RMD ResMed -8.4%7D -26.2%3M | US$190.57 33.9% undervalued intrinsic discount | PE 18.2x | E 9.2% | US$270.60 |